Allergan Sucks Customer Reviews and Feedback
Allergan plc is an Irish-domiciled pharmaceutical company that acquires, develops, manufactures, and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox. Allergan plc was formed in March 2015 when Irish–registered Actavis plc acquired the U.S.–registered Allergan, Inc., and assumed the Allergan name. n 2016, Allergan sold its generic business, Actavis, to Teva for $40.5 billion. In June 2019, U.S. pharmaceutical company AbbVie announced it had reached an agreement to acquire Allergan for $63 billion. The merged company would be domiciled in the U.S. for tax purposes,
Back in February 2020 Allergan was accused of misleading CoolTone marketing in a new lawsuit from BTL, Beth Snyder Bulik wrote a piece for Fiercepharma:
Allergan has been hit with another lawsuit from BTL Industries. The Massachusetts-based company is alleging false and misleading advertising for Allergan’s CoolTone product, claiming Allergan's advertising uses “deceptive comparisons” to its own EmSculpt technology.
The lawsuit alleges Allergan marketing, sales materials, and social media advertising “feature numerous deceptive comparisons” of CoolTone to EmSculpt and misrepresents Allergan’s product performance over the BTL product. CoolTone and EmScuplt are both nonsurgical fat reduction technologies, a category that includes Allergan’s fat-freezing CoolSculpting treatments. In this case, the devices use different technologies to strengthen and tone muscle in targeted areas such as the abdomen, thighs, and buttocks.
Allergan’s response was simple and direct.
“The claims are baseless and will be defended vigorously,” Allergan said in an emailed statement to FiercePharma.
RELATED: Just in time for summer, Allergan brings back Real Housewife to promote fat-freezing treatment
It’s the second lawsuit filed by BTL in recent months. The first was filed in U.S. District Court in Delaware in December and alleges Allergan’s device infringes the U.S. patent of BTL’s machine.
The second, advertising-based lawsuit asks for a halt to the Allergan advertising, corrective marketing, damages and attorney fees.
Allergan’s CoolTone device received FDA clearance in June, while BTL’s EmSculpt is also FDA cleared and launched in 2018. Actress Drew Barrymore debuted as EmSculpt’s celebrity spokesperson in 2019 in a promotional partnership with BTL.
“While BTL welcomes fair competition and competitive advertising, it was the egregious and misleading nature of (Allergan) marketing that compelled us to file this lawsuit," Filip Donner, director of BTL Industries, said in a news release.
Hood County Substance Abuse Council says"RT @FEDUpRally: New York state filed civil charges on Tuesday accusing Teva Pharmaceutical Industries Ltd and Allergan Plc with insurance f…"
Pharma News says"Global Medical Aesthetics Market 2020-2026 is Growing So Rapidly || Leading Players –Allergan, Bausch Health Compan… https://t.co/CzYx4EkYBs"
costco_carts says"Milton's Gluten Free Everything Crackers, Harmless Harvet Organic Coconut Water, M&M's Peanut, Allergan Refresh Tea… https://t.co/DRRRWa1F7N"
Health Crisis Alert says"“Everyone who has been affected by opioids deserves justice, and we will make every effort to deliver it to them by… https://t.co/uVkQYJxbOL"
In The News
FiercePharma reports"New York wraps Allergan and Teva into ongoing opioid abuse probe with new civil charges"
WHTC News reports"New York charges Teva, Allergan with insurance fraud over opioid claims"
The Daily Chronicle reports"VEGF Targeted Drugs for Breast Cancer Market Projected to Witness Vigorous Expansion by 2020-2026 | , Genentech, Allergan"
WJLA reports"Breast implant maker tries new push to find patients one year after cancer related recall"